JPH069503A - Optically inactive low-molecular compound - Google Patents

Optically inactive low-molecular compound

Info

Publication number
JPH069503A
JPH069503A JP11525593A JP11525593A JPH069503A JP H069503 A JPH069503 A JP H069503A JP 11525593 A JP11525593 A JP 11525593A JP 11525593 A JP11525593 A JP 11525593A JP H069503 A JPH069503 A JP H069503A
Authority
JP
Japan
Prior art keywords
compound
liquid crystal
shown below
crystal composition
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11525593A
Other languages
Japanese (ja)
Inventor
Motohisa Ido
元久 井戸
Koyo Yuasa
公洋 湯浅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idemitsu Kosan Co Ltd
Original Assignee
Idemitsu Kosan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idemitsu Kosan Co Ltd filed Critical Idemitsu Kosan Co Ltd
Priority to JP11525593A priority Critical patent/JPH069503A/en
Publication of JPH069503A publication Critical patent/JPH069503A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

PURPOSE:To obtain an optically inactive low-molecular compound capable of providing a ferroelectric liquid crystal composition having a large tilt angle even by its addition into a liquid crystal composition so as to improve electric field responsiveness of the liquid crystal composition. CONSTITUTION:The compound of formula I (R<1> is formula II to VII, etc.; R<2> is 4-20C optically inactive alkyl; l and m are 0-10; n is 1-10; k is 1-20; Y is single bond, O, COO or OCO), e.g. a compound of formula VIII. This compound of formula VIII is obtained by converting a benzoic acid derivative into an acid chloride according to a pathway expressed by the reactional formula, then reacting the resultant acid chloride with a hydroxyphenylpyrimidine derivative and further reacting the obtained compound with trimethylacetic acid.

Description

【発明の詳細な説明】Detailed Description of the Invention

【産業上の利用分野】本発明は、オプトエレクトロニク
ス分野の液晶用材料として好適に用いられる非光学活性
低分子化合物に関する。
FIELD OF THE INVENTION The present invention relates to a non-optically active low molecular weight compound which is preferably used as a liquid crystal material in the field of optoelectronics.

【従来の技術】強誘電性高分子液晶の電界応答性を向上
させるために、高分子液晶化合物に複素環骨格を有し、
スメクチックC相を示す非光学活性な低分子液晶化合物
を添加した強誘電性高分子液晶組成物は知られている
(特開平4−59890号公報)。しかしながら、従来
知られている強誘電性高分子液晶組成物においては、低
分子液晶化合物の添加量が増えると、強誘電性高分子液
晶組成物のチルト角が大きく低下してしまい、コントラ
ストを悪くするという問題がある。分岐アルキル基を有
する非光学活性な低分子化合物として、下記の化合物
[1]〜[33]が独国特許出願公開第4003012
号明細書(化合物[1]〜[32])及び欧州特許出願
公開第0477901号明細書(化合物[33])に記
載されている。
2. Description of the Related Art In order to improve the electric field response of a ferroelectric polymer liquid crystal, a polymer liquid crystal compound has a heterocyclic skeleton,
A ferroelectric polymer liquid crystal composition to which a non-optically active low molecular weight liquid crystal compound exhibiting a smectic C phase is added is known (JP-A-4-59890). However, in the conventionally known ferroelectric polymer liquid crystal composition, when the addition amount of the low molecular weight liquid crystal compound is increased, the tilt angle of the ferroelectric polymer liquid crystal composition is largely decreased, resulting in poor contrast. There is a problem of doing. As the non-optically active low molecular weight compound having a branched alkyl group, the following compounds [1] to [33] are disclosed in German Patent Application Publication No. 4003012.
(Compounds [1] to [32]) and EP-A-0477901 (Compound [33]).

【化3】 [Chemical 3]

【化4】 しかしながら、これらの低分子化合物を強誘電性高分子
液晶に添加して液晶組成物を調製しても、数日で結晶が
析出して層分離が起こり、長期的安定性に欠けるという
問題点がある。
[Chemical 4] However, even if these low molecular weight compounds are added to a ferroelectric polymer liquid crystal to prepare a liquid crystal composition, there is a problem in that crystals are separated in several days and layer separation occurs, resulting in lack of long-term stability. is there.

【発明が解決しようとする課題】本発明は強誘電性液晶
組成物を調製する際に、液晶組成物の電界応答性を向上
させるために組成物中に添加してもチルト角の大きい強
誘電性液晶組成物が得られ、かつ強誘電性高分子液晶に
添加した際結晶を析出しにくい長期的安定性を有する組
成物を提供しうる新規な非光学活性低分子化合物を提供
することを目的とする。
DISCLOSURE OF THE INVENTION The present invention provides a ferroelectric liquid crystal having a large tilt angle even when it is added to the composition in order to improve the electric field response of the liquid crystal composition when preparing the ferroelectric liquid crystal composition. PROBLEM TO BE SOLVED: To provide a novel non-optically active low molecular compound capable of providing a composition having a long-term stability in which a crystalline liquid crystal composition can be obtained and crystals are hardly precipitated when added to a ferroelectric polymer liquid crystal. And

【課題を解決するための手段】本発明者らは前記課題を
解決するために鋭意研究を行った結果、分子末端に特定
な分岐状のアルキル基を有し、更に、その分岐中心炭素
と骨格部との間に、COO及びOといったヘテロ原子か
らなる官能基を二つ導入した非光学活性低分子化合物が
チルト角の大きい強誘電性液晶組成物を与えることを見
出した。更に、この化合物が強誘電性高分子液晶に添加
しても結晶化を起こしにくく、層分離を起こしにくいこ
とを見出した。これらの知見に基づいて本発明を完成す
るに至った。すなわち、本発明は下記一般式で表わされ
る非光学活性低分子化合物を提供するものである。
Means for Solving the Problems As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that they have a specific branched alkyl group at the end of the molecule, and further have a branched central carbon and skeleton. It has been found that a non-optically active low molecular weight compound in which two functional groups composed of heteroatoms such as COO and O are introduced between the compound and the moiety gives a ferroelectric liquid crystal composition having a large tilt angle. Furthermore, they have found that even if this compound is added to a ferroelectric polymer liquid crystal, it is unlikely to cause crystallization and layer separation. The present invention has been completed based on these findings. That is, the present invention provides a non-optically active low molecular weight compound represented by the following general formula.

【化5】 (式中、R1[Chemical 5] (In the formula, R 1 is

【化6】 を表わし、R2は炭素数4〜20の非光学活性なアルキル
基、lは0〜10の整数、mは0〜10の整数、nは1
〜10の整数、kは1〜20の整数、Yは単結合、O、CO
O又はOCOを表わす。) 本発明の新規非光学活性低分子化合物は液晶組成物を調
製する際に、強誘電性高分子液晶に添加してもチルト角
の大きさが大きく、かつ、相分離を起こしにくい安定な
液晶組成物が得られ、例えばゲスト−ホスト型駆動用液
晶組成物の調製にあたり、有用な構成成分となりうるも
のである。本発明の非光学活性低分子化合物の末端部位
にある分岐状のアルキル基の具体例としては、例えば次
のような基を挙げることができる。
[Chemical 6] R 2 is a non-optically active alkyl group having 4 to 20 carbon atoms, l is an integer of 0 to 10, m is an integer of 0 to 10, and n is 1
-10 integer, k 1-20 integer, Y single bond, O, CO
Represents O or OCO. ) The novel non-optically active low molecular weight compound of the present invention is a stable liquid crystal having a large tilt angle even when added to a ferroelectric polymer liquid crystal when preparing a liquid crystal composition and hardly causing phase separation. The composition can be obtained and can be a useful constituent component in the preparation of, for example, a guest-host type driving liquid crystal composition. Specific examples of the branched alkyl group at the terminal portion of the non-optically active low molecular weight compound of the present invention include the following groups.

【化7】 $ 本発明の非光学活性低分子化合物の具体例としては、例
えば次のような化合物を挙げることができる。
[Chemical 7] $ Specific examples of the non-optically active low molecular weight compound of the present invention include the following compounds.

【化8】 [Chemical 8]

【化9】 [Chemical 9]

【実施例】以下、本発明を実施例に基づいて詳細に説明
するが、本発明はこれに限定されるものではない。 実施例1 化合物(1)の合成 以下に示す合成経路に従って化合物(1)を合成した。
EXAMPLES The present invention will now be described in detail based on examples, but the present invention is not limited thereto. Example 1 Synthesis of Compound (1) Compound (1) was synthesized according to the synthetic route shown below.

【化10】 $ (1−1)化合物(16)の合成 安息香酸誘導体(14)9.16gのトルエン50ml
溶液に塩化チオニル11.33g、ピリジン数滴を加
え、65℃で4時間反応させた。アスピレーターを取り
付け、65℃で30分間、更に80℃で1時間かけて、
溶媒及び過剰の塩化チオニルを留去した。残った油状物
質に、ピリジン1.88gのトルエン50ml溶液、及
びヒドロキシフェニルピリミジン誘導体(15)7.4
6gのトルエン50ml溶液を滴下した。室温で12時
間反応させた後、瀘過を行い塩を除去した。瀘液から減
圧で溶媒を留去し、残渣をカラムクロマトグラフィー
(中性アルミナ充填プレカラム、シリカゲル充填メイン
カラム、10%酢酸エチル/20%ジクロロメタン/n
−ヘキサン展開)により精製することで、目的とする化
合物(16)9.31gを得た(収率58%)。1H−
NMR(TMS/CDCl3)の分析結果(ppm)を下記
に示す。 8.55(s,2H) 4.00(t,2H) 8.45(d,2H) 3.38(t,2H) 8.10(d,2H) 2.58(t,2H) 7.38(d,2H) 2.10〜0.70(m,39
H) 6.90(d,2H) $ (1−2)化合物(1)の合成 トリメチル酢酸2.77gとテトラメチルアンモニウム
ヒドロキサイド5水和物4.92gを透明な液体になる
まで室温で攪拌した後、DMF50mlを加えた。化合
物(16)9.20gのDMF550ml溶液を加え、
40℃で12時間反応させた。反応終了後、反応混合物
を希塩酸水溶液に注ぎ、ジクロロメタンで抽出した。有
機層を硫酸マグネシウム(無水)で乾燥した後、瀘過を
行い、瀘液から減圧で溶媒を留去した。残渣をカラムク
ロマトグラフィー(シリカゲル充填、10%酢酸エチル
/20%ジクロロメタン/n−ヘキサン展開)により精
製することで、目的とする化合物(1)7.47gを得
た(収率79%)。得られた化合物の1H−NMR(T
MS/CDCl3)の分析結果(ppm)を下記に示す。 8.55(s,2H) 4.00(m,4H) 8.45(d,2H) 2.56(t,2H) 8.10(d,2H) 2.10〜0.70(m,48
H) 7.39(d,2H) 6.90(d,2H) また、偏光顕微鏡観察による化合物(1)の相転移挙動
(降温過程)は以下の通りであった。 Iso → N → SC → S1 → Cryst. 103℃ 88℃ 60℃ 40℃ (Iso:等方相、N:ネマチック相、SC:スメクチ
ックC相、S1:未同定のスメクチック相、Crys
t.:結晶相) $ 実施例2 化合物(2)の合成 以下に示す合成経路に従って化合物(2)を合成した。
[Chemical 10] $ (1-1) Synthesis of compound (16) Benzoic acid derivative (14) 9.16 g toluene 50 ml
11.33 g of thionyl chloride and a few drops of pyridine were added to the solution, and the mixture was reacted at 65 ° C. for 4 hours. Attach an aspirator for 30 minutes at 65 ° C and then 1 hour at 80 ° C.
The solvent and excess thionyl chloride were distilled off. To the remaining oily substance, a solution of 1.88 g of pyridine in 50 ml of toluene and a hydroxyphenylpyrimidine derivative (15) 7.4.
A solution of 6 g of toluene in 50 ml was added dropwise. After reacting for 12 hours at room temperature, filtration was performed to remove salts. The solvent was distilled off from the filtrate under reduced pressure, and the residue was subjected to column chromatography (neutral alumina-filled precolumn, silica gel-filled main column, 10% ethyl acetate / 20% dichloromethane / n).
-Development with hexane) to obtain 9.31 g of the target compound (16) (yield 58%). 1 H-
The analysis results (ppm) of NMR (TMS / CDCl 3 ) are shown below. 8.55 (s, 2H) 4.00 (t, 2H) 8.45 (d, 2H) 3.38 (t, 2H) 8.10 (d, 2H) 2.58 (t, 2H) 7. 38 (d, 2H) 2.10 to 0.70 (m, 39
H) 6.90 (d, 2H) $ (1-2) Synthesis of compound (1) 2.77 g of trimethylacetic acid and 4.92 g of tetramethylammonium hydroxide pentahydrate were stirred at room temperature until a transparent liquid was obtained. After that, 50 ml of DMF was added. A solution of 9.20 g of compound (16) in 550 ml of DMF was added,
The reaction was carried out at 40 ° C for 12 hours. After completion of the reaction, the reaction mixture was poured into a dilute hydrochloric acid aqueous solution and extracted with dichloromethane. The organic layer was dried over magnesium sulfate (anhydrous) and then filtered, and the solvent was distilled off from the filtrate under reduced pressure. The residue was purified by column chromatography (filled with silica gel, 10% ethyl acetate / 20% dichloromethane / n-hexane development) to obtain 7.47 g of the target compound (1) (yield 79%). 1 H-NMR (T
The analysis results (ppm) of MS / CDCl 3 ) are shown below. 8.55 (s, 2H) 4.00 (m, 4H) 8.45 (d, 2H) 2.56 (t, 2H) 8.10 (d, 2H) 2.10 to 0.70 (m, 48
H) 7.39 (d, 2H) 6.90 (d, 2H) Further, the phase transition behavior (temperature lowering process) of the compound (1) observed by a polarization microscope was as follows. Iso → N → S C → S 1 → Cryst. 103 ° C. 88 ° C. 60 ° C. 40 ° C. (Iso: isotropic phase, N: nematic phase, S C : smectic C phase, S 1 : unidentified smectic phase, Crys
t. : Crystalline phase) $ Example 2 Synthesis of compound (2) Compound (2) was synthesized according to the synthetic route shown below.

【化11】 $ (2−1)化合物(18)の合成 ヒドロキシフェニルピリミジン誘導体(15)の代りに
ヒドロキシビフェニルカルボン酸誘導体(17)を用
い、実施例1(1−1)と同様な操作を行うことによ
り、化合物(17)2.00gから目的とする化合物
(18)2.80gを得た(収率66%)。1H−NM
R(TMS/CDCl3)の分析結果(ppm)を下記に示
す。 8.05(d,2H) 4.00(m,4H) 8.04(d,2H) 3.35(t,2H) 7.57(d,2H) 2.10〜0.85(m,35
H) 7.56(d,2H) 7.23(d,2H) 6.90(d,2H) $ (2−2)化合物(2)の合成 化合物(16)の代りに化合物(18)を用い、実施例
1(1−2)と同様な操作を行うことにより、化合物
(18)1.80gから目的とする化合物(2)0.7
0gを得た(収率38%)。1H−NMR(TMS/CDC
l3)の分析結果(ppm)を下記に示す。 8.05(d,2H) 4.00(m,6H) 8.04(d,2H) 2.10〜0.75(m,43
H) 7.57(d,2H) 7.56(d,2H) 7.23(d,2H) 6.90(d,2H) また、偏光顕微鏡観察による化合物(2)の相転移挙動
(降温過程)は以下の通りであった。 Iso → SA → SC → Cryst. 133℃ 126℃ 68℃ (SA:スメクチックA相) $ 実施例3 化合物(3)の合成 以下に示す合成経路に従って化合物(3)を合成した。
[Chemical 11] $ (2-1) Synthesis of compound (18) By using hydroxybiphenylcarboxylic acid derivative (17) in place of hydroxyphenylpyrimidine derivative (15) and performing the same operation as in Example 1 (1-1), 2.80 g of the target compound (18) was obtained from 2.00 g of the compound (17) (yield 66%). 1 H-NM
The analysis results (ppm) of R (TMS / CDCl 3 ) are shown below. 8.05 (d, 2H) 4.00 (m, 4H) 8.04 (d, 2H) 3.35 (t, 2H) 7.57 (d, 2H) 2.10 to 0.85 (m, 35
H) 7.56 (d, 2H) 7.23 (d, 2H) 6.90 (d, 2H) $ (2-2) Synthesis of compound (2) Compound (18) was used in place of compound (16) Using the same procedure as in Example 1 (1-2), the desired compound (2) 0.7 was obtained from 1.80 g of the compound (18).
0 g was obtained (yield 38%). 1 H-NMR (TMS / CDC
The analysis result (ppm) of l 3 ) is shown below. 8.05 (d, 2H) 4.00 (m, 6H) 8.04 (d, 2H) 2.10 to 0.75 (m, 43)
H) 7.57 (d, 2H) 7.56 (d, 2H) 7.23 (d, 2H) 6.90 (d, 2H) Also, the phase transition behavior of the compound (2) by polarization microscope observation (temperature decrease). The process) was as follows. Iso → S A → S C → Cryst. 133 ° C. 126 ° C. 68 ° C. (S A : Smectic A phase) $ Example 3 Synthesis of compound (3) Compound (3) was synthesized according to the synthetic route shown below.

【化12】 (3−1)化合物(21)の合成 カルボン酸誘導体(14)の代りに化合物(19)を、
化合物(15)の代りに化合物(20)をそれぞれ用
い、実施例1(1−1)と同様な操作を行うことによ
り、化合物(20)0.77gから目的とする化合物
(21)0.80gを得た(収率34%)。1H−NM
R(TMS/CDCl3)の分析結果(ppm)を下記に示
す。 8.25〜6.75(m,12H) 4.00 (m,4H) 3.38 (t,2H) 2.10〜0.75(m,35H) $ (3−2)化合物(3)の合成 化合物(16)の代りに化合物(21)を用い、実施例
1(1−2)と同様な操作を行うことにより、化合物
(21)0.80gから目的とする化合物(3)0.4
1gを得た(収率50%)。1H−NMR(TMS/CDC
l3)の分析結果(ppm)を下記に示す。 8.25〜6.75(m,12H) 4.00 (m,6H) 2.10〜0.75(m,44H) また、偏光顕微鏡観察による化合物(3)の相転移挙動
(降温過程)は以下の通りであった。 Iso → SA → SC → Cryst. 156℃ 146℃ 80℃ $ 実施例4 化合物(4)の合成 以下に示す合成経路に従って化合物(4)を合成した。
[Chemical 12] (3-1) Synthesis of compound (21) Instead of the carboxylic acid derivative (14), the compound (19) is used.
The compound (20) was used in place of the compound (15) and the same operation as in Example 1 (1-1) was carried out to obtain 0.77 g of the compound (20) and 0.80 g of the desired compound (21). Was obtained (yield 34%). 1 H-NM
The analysis results (ppm) of R (TMS / CDCl 3 ) are shown below. 8.25-6.75 (m, 12H) 4.00 (m, 4H) 3.38 (t, 2H) 2.10-0.75 (m, 35H) $ (3-2) Compound (3) Synthesis of compound (16) was replaced with compound (21), and the same operation as in Example 1 (1-2) was carried out. Four
1 g was obtained (yield 50%). 1 H-NMR (TMS / CDC
The analysis result (ppm) of l 3 ) is shown below. 8.25 to 6.75 (m, 12H) 4.00 (m, 6H) 2.10 to 0.75 (m, 44H) Further, the phase transition behavior of the compound (3) by polarization microscope observation (cooling process) Was as follows: Iso → S A → S C → Cryst. 156 ° C. 146 ° C. 80 ° C. $ Example 4 Synthesis of compound (4) Compound (4) was synthesized according to the synthetic route shown below.

【化13】 $ (4−1)化合物(23)の合成 化合物(15)の代りに化合物(22)を用い、実施例
1(1−1)と同様な操作を行うことにより、化合物
(22)1.08gから目的とする化合物(23)2.
10gを得た(収率70%)。1H−NMR(TMS/C
DCl3)の分析結果(ppm)を下記に示す。 8.10 (d,2H) 7.20〜6.80(m,6H) 4.00 (m,4H) 3.86 (t,2H) 2.10〜0.80(m,33H) $ (4−2)化合物(4)の合成 化合物(16)の代りに化合物(23)を用い、実施例
1(1−2)と同様な操作を行うことにより、化合物
(23)2.10gから目的とする化合物(4)1.5
0gを得た(収率70%)。1H−NMR(TMS/CDC
l3)の分析結果(ppm)を下記に示す。 8.10 (d,2H) 7.20〜6.80(m,6H) 4.00 (m,6H) 2.10〜0.75(m,42H) また、偏光顕微鏡観察による化合物(4)の相転移挙動
(降温過程)は以下の通りであった。 Iso → SA → SC → S1 → Cryst. 57℃ 41℃ 31℃ 4℃ $ 実施例5 化合物(5)の合成 以下に示す合成経路に従って化合物(5)を合成した。
[Chemical 13] $ (4-1) Synthesis of compound (23) Compound (22) 1.08 g was obtained by substituting compound (22) for compound (15) and performing the same operation as in Example 1 (1-1). To the target compound (23) 2.
10 g was obtained (yield 70%). 1 H-NMR (TMS / C
The analysis results (ppm) of DCl 3 ) are shown below. 8.10 (d, 2H) 7.20 to 6.80 (m, 6H) 4.00 (m, 4H) 3.86 (t, 2H) 2.10 to 0.80 (m, 33H) $ ( 4-2) Synthesis of compound (4) By using compound (23) instead of compound (16) and performing the same operation as in Example 1 (1-2), 2.10 g of compound (23) was obtained. Compound (4) 1.5
0 g was obtained (yield 70%). 1 H-NMR (TMS / CDC
The analysis result (ppm) of l 3 ) is shown below. 8.10 (d, 2H) 7.20 to 6.80 (m, 6H) 4.00 (m, 6H) 2.10 to 0.75 (m, 42H) Further, the compound (4) observed by a polarizing microscope. The phase transition behavior (cooling process) of was as follows. Iso → S A → S C → S 1 → Cryst. 57 ° C. 41 ° C. 31 ° C. 4 ° C. $ Example 5 Synthesis of compound (5) Compound (5) was synthesized according to the synthetic route shown below.

【化14】 $ (5−1)化合物(24)の合成 化合物(15)の代りに化合物(20)を用い、実施例
1(1−1)と同様な操作を行うことにより、化合物
(20)1.15gから目的とする化合物(24)2.
00gを得た(収率65%)。1H−NMR(TMS/C
DCl3)の分析結果(ppm)を下記に示す。 8.10 (d,2H) 7.20〜6.80(m,6H) 4.00 (m,4H) 3.87 (t,2H) 2.10〜0.85(m,35H) $ (5−2)化合物(5)の合成 化合物(16)の代りに化合物(24)を用い、実施例
1(1−2)と同様な操作を行うことにより、化合物
(24)2.00gから目的とする化合物(5)1.5
0gを得た(収率72%)。1H−NMR(TMS/CDC
l3)の分析結果(ppm)を下記に示す。 8.10 (d,2H) 7.20〜6.80(m,6H) 4.00 (m,6H) 2.10〜0.85(m,44H) また、偏光顕微鏡観察による化合物(5)の相転移挙動
(降温過程)は以下の通りであった。 Iso → SA → SC → S1 → Cryst. 58℃ 45℃ 33℃ 18℃ $ 実施例6 化合物(6)の合成 以下に示す合成経路に従って化合物(6)を合成した。
[Chemical 14] $ (5-1) Synthesis of compound (24) Using compound (20) instead of compound (15) and performing the same operation as in Example 1 (1-1), 1.15 g of compound (20) To the target compound (24) 2.
00g was obtained (yield 65%). 1 H-NMR (TMS / C
The analysis results (ppm) of DCl 3 ) are shown below. 8.10 (d, 2H) 7.20 to 6.80 (m, 6H) 4.00 (m, 4H) 3.87 (t, 2H) 2.10 to 0.85 (m, 35H) $ ( 5-2) Synthesis of compound (5) Using compound (24) instead of compound (16) and performing the same operation as in Example 1 (1-2), 2.00 g of compound (24) was obtained. Compound (5) 1.5
0 g was obtained (yield 72%). 1 H-NMR (TMS / CDC
The analysis result (ppm) of l 3 ) is shown below. 8.10 (d, 2H) 7.20 to 6.80 (m, 6H) 4.00 (m, 6H) 2.10 to 0.85 (m, 44H) Further, the compound (5) observed by a polarizing microscope. The phase transition behavior (cooling process) of was as follows. Iso → S A → S C → S 1 → Cryst. 58 ° C. 45 ° C. 33 ° C. 18 ° C. $ Example 6 Synthesis of compound (6) Compound (6) was synthesized according to the synthetic route shown below.

【化15】 $ (6−1)化合物(25)の合成 DMF14mlに60%油性水素化ナトリウム1.50
gを加え、更に、ヒドロキシフェニルピリミジン誘導体
(15)7.83gのDMF50ml溶液を室温で滴下
した。そのまま室温で30分間攪拌した後、1,8−ジ
ブロモオクタン20.40gのDMF50ml溶液を滴
下し、更に8時間攪拌した。反応終了後、反応混合物を
水に注ぎ、ジクロロメタンで抽出した。有機層を無水硫
酸マグネシウムで乾燥した後、瀘過を行い、瀘液を減圧
で留去することにより残渣52.80gを得た。これを
カラムクロマトグラフィー(シリカゲル充填、10%酢
酸エチル/20%ジクロロメタン/n−ヘキサン展開)
により精製することで、目的とする化合物(25)7.
70gを得た(収率61%)。1H−NMR(TMS/C
DCl3)の分析結果(ppm)を下記に示す。 8.50 (s,2H) 8.33 (d,2H) 7.00 (d,2H) 4.10 (t,2H) 3.36 (t,2H) 2.60 (t,2H) 2.10〜0.85(m,31H) $ (6−2)化合物(6)の合成 化合物(16)の代りに化合物(25)を用い、実施例
1(1−2)と同様な操作を行うことにより、化合物
(25)1.01gから目的とする化合物(6)0.9
1gを得た(収率87%)。1H−NMR(TMS/CDC
l3)の分析結果(ppm)を下記に示す。 8.50 (s,2H) 8.33 (d,2H) 7.00 (d,2H) 4.10 (t,2H) 4.00 (t,2H) 2.60 (t,2H) 2.10〜0.85(m,40H) また、偏光顕微鏡観察による化合物(6)の相転移挙動
(降温過程)は以下の通りであった。 Iso → SA → SC → Cryst. 76℃ 54℃ 25℃ $ 実施例7 化合物(7)の合成 以下に示す合成経路に従って化合物(7)を合成した。
[Chemical 15] $ (6-1) Synthesis of Compound (25) DMF 14 ml contains 60% oily sodium hydride 1.50
g, and further, a solution of 7.83 g of the hydroxyphenylpyrimidine derivative (15) in 50 ml of DMF was added dropwise at room temperature. After stirring at room temperature for 30 minutes as it was, a solution of 20.40 g of 1,8-dibromooctane in 50 ml of DMF was added dropwise, and the mixture was further stirred for 8 hours. After completion of the reaction, the reaction mixture was poured into water and extracted with dichloromethane. The organic layer was dried over anhydrous magnesium sulfate and then filtered, and the filtrate was distilled off under reduced pressure to obtain 52.80 g of a residue. Column chromatography (packing silica gel, developing 10% ethyl acetate / 20% dichloromethane / n-hexane)
The compound of interest (25) 7.
70 g was obtained (61% yield). 1 H-NMR (TMS / C
The analysis results (ppm) of DCl 3 ) are shown below. 8.50 (s, 2H) 8.33 (d, 2H) 7.00 (d, 2H) 4.10 (t, 2H) 3.36 (t, 2H) 2.60 (t, 2H) 2. 10-0.85 (m, 31H) $ (6-2) Synthesis of Compound (6) The compound (25) is used instead of the compound (16), and the same operation as in Example 1 (1-2) is performed. Thus, from 1.01 g of the compound (25), the target compound (6) 0.9
1 g was obtained (87% yield). 1 H-NMR (TMS / CDC
The analysis result (ppm) of l 3 ) is shown below. 8.50 (s, 2H) 8.33 (d, 2H) 7.00 (d, 2H) 4.10 (t, 2H) 4.00 (t, 2H) 2.60 (t, 2H) 2. 10-0.85 (m, 40H) Moreover, the phase transition behavior (temperature-decreasing process) of the compound (6) by a polarization microscope observation was as follows. Iso → S A → S C → Cryst. 76 ° C. 54 ° C. 25 ° C. $ Example 7 Synthesis of compound (7) Compound (7) was synthesized according to the synthetic route shown below.

【化16】 (7−1)化合物(27)の合成 化合物(15)の代りに化合物(26)を、1,8−ジ
ブロモオクタンの代りに1,12−ジブロモドデカンを
用い、実施例6(6−1)と同様な操作を行うことによ
り、化合物(26)3.00gから目的とする化合物
(27)3.28gを得た(収率60%)。1H−NM
R(TMS/CDCl3)の分析結果(ppm)を下記に示
す。 8.40 (s,2H) 8.25 (d,2H) 6.95 (d,2H) 4.05 (m,4H) 3.36 (t,2H) 2.10〜0.85(m,35H) $ (7−2)化合物(7)の合成 化合物(16)の代りに化合物(27)を用い、実施例
1(1−2)と同様な操作を行うことにより、化合物
(27)1.10gから目的とする化合物(7)1.0
3gを得た(収率91%)。1H−NMR(TMS/CDC
l3)の分析結果(ppm)を下記に示し、NMRチャー
トを図1に示す。 8.40 (s,2H) 8.25 (d,2H) 6.95 (d,2H) 4.05 (m,6H) 1.90〜0.85(m,44H) また、偏光顕微鏡観察による化合物(7)の相転移挙動
(降温過程)は以下の通りであった。 $ 実施例8、9、10、11、12、13、14及び比較
例1 下記の構造を有する強誘電性高分子液晶化合物(28)
に、本発明の化合物(1)、(2)、(3)、(4)、
(5)、(6)、(7)を30重量%添加した液晶組成
物を調製した。液晶組成物の調製は、組成物の構成成分
全てをその重量の1.5倍の重量のジクロロメタンに溶
解して均一溶液とした後、溶媒を留去することによって
行った。更に、2枚のITO電極付ガラス基板間に、こ
れらの組成物を挟み、シアリング法によりセル厚約3μ
mの配向セルを作製し、±15MV/mの電界を印加し
ながらチルト角を測定した。更に、比較のため、強誘電
性高分子液晶化合物(28)に分子末端に分岐アルキル
基のない公知の下記化合物(29)(みどり化学社製P
−1008)を30重量%添加した組成物を用いて、実
施例8〜14と同様にセルを作製し、同様にチルト角
(2θ)を測定した。
[Chemical 16] (7-1) Synthesis of Compound (27) Example 6 (6-1) using Compound (26) in place of Compound (15) and 1,12-Dibromododecane in place of 1,8-Dibromooctane. By carrying out the same operation as above, 3.28 g of the desired compound (27) was obtained from 3.00 g of the compound (26) (yield 60%). 1 H-NM
The analysis results (ppm) of R (TMS / CDCl 3 ) are shown below. 8.40 (s, 2H) 8.25 (d, 2H) 6.95 (d, 2H) 4.05 (m, 4H) 3.36 (t, 2H) 2.10 to 0.85 (m, 35H) $ (7-2) Synthesis of Compound (7) Compound (27) 1 was prepared by the same procedure as in Example 1 (1-2) using compound (27) instead of compound (16). The target compound (7) 1.0 from 10 g
3 g was obtained (yield 91%). 1 H-NMR (TMS / CDC
The result of analysis (ppm) of l 3 ) is shown below, and the NMR chart is shown in FIG. 8.40 (s, 2H) 8.25 (d, 2H) 6.95 (d, 2H) 4.05 (m, 6H) 1.90 to 0.85 (m, 44H) In addition, by polarization microscope observation The phase transition behavior (temperature lowering process) of the compound (7) was as follows. $ Examples 8, 9, 10, 11, 12, 13, 14 and Comparative Example 1 Ferroelectric polymer liquid crystal compound (28) having the following structure
To the compounds (1), (2), (3), (4), and
A liquid crystal composition containing 30% by weight of (5), (6) and (7) was prepared. The liquid crystal composition was prepared by dissolving all the constituent components of the composition in 1.5 times the weight of dichloromethane to form a uniform solution, and then distilling off the solvent. Further, by sandwiching these compositions between two glass substrates with ITO electrodes, a cell thickness of about 3 μm was obtained by the shearing method.
An oriented cell of m was prepared and the tilt angle was measured while applying an electric field of ± 15 MV / m. Further, for comparison, a known compound (29) having no branched alkyl group at the molecular end of the ferroelectric polymer liquid crystal compound (28) (P, manufactured by Midori Kagaku Co., Ltd.)
-1008) was added to the composition, and cells were prepared in the same manner as in Examples 8 to 14, and the tilt angle (2θ) was measured in the same manner.

【化17】 実施例8〜14及び比較例1の結果を表1に示す。[Chemical 17] The results of Examples 8 to 14 and Comparative Example 1 are shown in Table 1.

【表1】 $ 実施例15 化合物(8)の合成 以下に示す合成経路に従って化合物(8)を合成した。[Table 1] $ Example 15 Synthesis of compound (8) Compound (8) was synthesized according to the synthetic route shown below.

【化18】 $ (±)−2−メチルバレリックアシッド0.232gと
テトラメチルアンモニウムヒドロキサイド5水和物0.
362gを透明な液体になるまで室温で攪拌した後、D
MF4mlを加えた。化合物(16)0.680gのD
MF40ml溶液を加え、40℃で12時間反応させ
た。反応終了後、反応混合物を希塩酸水溶液に注ぎ、ジ
クロロメタンで抽出した。有機層を硫酸マグネシウム
(無水)で乾燥した後、瀘過を行い、瀘液から減圧で溶
媒を留去した。残渣をカラムクロマトグラフィー(シリ
カゲル充填、10%酢酸エチル/20%ジクロロメタン
/n−ヘキサン展開)により精製することで、目的とす
る化合物(8)0.601gを得た(収率84.1
%)。1H−NMR(TMS/CDCl3)の分析結果(pp
m)を下記に示す。 8.61(s,2H) 2.62(t,2H) 8.48(d,2H) 2.43(m,1H) 8.15(d,2H) 1.86−1.20(m,40
H) 7.32(d,2H) 1.14(d,3H) 6.97(d,2H) 0.90(m,6H) 4.05(m,4H) また、偏光顕微鏡による化合物(8)の相転移挙動(降
温過程)は以下の通りであった。 Iso → N → SA → Cryst. 102℃ 89℃ 19℃ $ 実施例16 化合物(9)の合成 以下に示す合成経路に従って化合物(9)を合成した。
[Chemical 18] $ (±) -2-methylvaleric acid 0.232 g and tetramethylammonium hydroxide pentahydrate 0.
After stirring 362 g at room temperature until it became a transparent liquid, D
4 ml of MF was added. Compound (16) 0.680 g of D
A 40 ml MF solution was added and reacted at 40 ° C. for 12 hours. After completion of the reaction, the reaction mixture was poured into a dilute hydrochloric acid aqueous solution and extracted with dichloromethane. The organic layer was dried over magnesium sulfate (anhydrous) and then filtered, and the solvent was distilled off from the filtrate under reduced pressure. The residue was purified by column chromatography (filled with silica gel, 10% ethyl acetate / 20% dichloromethane / n-hexane development) to obtain 0.601 g of the desired compound (8) (yield 84.1).
%). 1 H-NMR (TMS / CDCl 3 ) analysis results (pp
m) is shown below. 8.61 (s, 2H) 2.62 (t, 2H) 8.48 (d, 2H) 2.43 (m, 1H) 8.15 (d, 2H) 1.86-1.20 (m, 40
H) 7.32 (d, 2H) 1.14 (d, 3H) 6.97 (d, 2H) 0.90 (m, 6H) 4.05 (m, 4H) Moreover, the compound (8 The phase transition behavior of () (temperature lowering process) was as follows. Iso → N → S A → Cryst . 102 ° C. 89 ° C. 19 ° C. $ Example 16 Synthesis of compound (9) Compound (9) was synthesized according to the synthetic route shown below.

【化19】 $ (±)−2−メチルバレリックアシッドの代りに(±)
−3−メチルバレリックアシッドを用い、実施例15と
同様な操作を行うことにより、化合物(16)0.68
0gから、目的とする化合物(9)0.634gを得た
(収率88.7%)。得られた化合物の1H−NMR
(TMS/CDCl3)分析の結果(ppm)を下記に示
す。 8.62(s,2H) 2.63(t,2H) 8.48(d,2H) 2.30(m,1H) 8.15(d,2H) 2.10(m,1H) 7.33(d,2H) 1.98−1.18(m,39
H) 6.97(d,2H) 0.90(m,9H) 4.06(m,4H) また、偏光顕微鏡観察による化合物(9)の相転移挙動
(降温過程)は以下の下の通りであった。 Iso → N → SA → S1 → glass 105℃ 93℃ 43℃ 32℃ (glass:ガラス状態) $ 実施例17 化合物(10)の合成 以下に示す合成経路に従って化合物(10)を合成し
た。
[Chemical 19] $ (±) -2- (±) instead of methylvaleric acid
Compound (16) 0.68 was prepared by the same procedure as in Example 15 using -3-methylvaleric acid.
0.634 g of the target compound (9) was obtained from 0 g (yield 88.7%). 1 H-NMR of the obtained compound
The results (ppm) of the (TMS / CDCl 3 ) analysis are shown below. 8.62 (s, 2H) 2.63 (t, 2H) 8.48 (d, 2H) 2.30 (m, 1H) 8.15 (d, 2H) 2.10 (m, 1H) 7. 33 (d, 2H) 1.98-1.18 (m, 39
H) 6.97 (d, 2H) 0.90 (m, 9H) 4.06 (m, 4H) Further, the phase transition behavior (temperature-decreasing process) of the compound (9) observed by a polarization microscope is as follows. Met. Iso → N → S A → S 1 → glass 105 ℃ 93 ℃ 43 ℃ 32 ℃: Compound (10) was synthesized according to the synthetic route shown in synthesis following (Glass glass state) $ Example 17 Compound (10).

【化20】 $ (±)−2−メチルバレリックアシッドの代りにイソバ
レリックアシッドを、化合物(16)の代りに化合物
(25)を用い、実施例15と同様な操作を行うことに
より、化合物(25)1.01gから目的とする化合物
(10)0.93gを得た(収率89%)。得られた化
合物の1H−NMR(TMS/CDCl3)分析の結果(pp
m)を下記に示す。 8.56(s,2H) 2.10(m,1H) 8.34(d,2H) 1.80(m,2H) 6.97(d,2H) 1.62(m,2H) 4.05(m,4H) 1.54−1.20(m,24
H) 2.58(t,2H) 0.95(d,6H) 2.18(d,2H) 0.87(t,3H) また、偏光顕微鏡観察による化合物(10)の相転移挙
動(降温過程)は以下の下の通りであった。 Iso → SA → SC → Cryst. 52.3℃ 33℃ 10℃ $ 実施例18 化合物(11)の合成 以下に示す合成経路に従って化合物(11)を合成し
た。
[Chemical 20] Compound (25) 1 was obtained by the same procedure as in Example 15 using isovaleric acid instead of $ (±) -2-methylvaleric acid and compound (25) instead of compound (16). 0.93 g of the target compound (10) was obtained from 0.01 g (yield 89%). Result of 1 H-NMR (TMS / CDCl 3 ) analysis of the obtained compound (pp
m) is shown below. 8.56 (s, 2H) 2.10 (m, 1H) 8.34 (d, 2H) 1.80 (m, 2H) 6.97 (d, 2H) 1.62 (m, 2H) 4. 05 (m, 4H) 1.54-1.20 (m, 24
H) 2.58 (t, 2H) 0.95 (d, 6H) 2.18 (d, 2H) 0.87 (t, 3H) Further, the phase transition behavior of the compound (10) (temperature decrease The process) was as follows. Iso → S A → S C → Cryst. 52.3 ° C. 33 ° C. 10 ° C. $ Example 18 Synthesis of Compound (11) Compound (11) was synthesized according to the synthetic route shown below.

【化21】 $ (±)−2−メチルバレリックアシッドの代りにイソブ
チリックアシッドを用い、実施例15と同様な操作を行
うことにより、化合物(16)0.680gから、目的
とする化合物(11)0.493gを得た(収率71.
8%)。得られた化合物の1H−NMR(TMS/CDC
l3)分析の結果(ppm)を下記に示す。 8.61(s,2H) 2.63(t,2H) 8.48(d,2H) 2.54(m,1H) 8.15(d,2H) 1.87−1.20(m,36
H) 7.32(d,2H) 1.16(d,6H) 6.98(d,2H) 0.88(t,3H) 4.05(m,4H) また、偏光顕微鏡観察による化合物(11)の相転移挙
動(降温過程)は以下の下の通りであった。 Iso → N → SC → S1 → Cryst. 115℃ 99℃ 38℃ 32℃ $ 実施例19 化合物(12)の合成 以下に示す合成経路に従って化合物(12)を合成し
た。
[Chemical 21] By using isobutyric acid instead of $ (±) -2-methylvaleric acid and performing the same operation as in Example 15, from the compound (16) 0.680 g to the target compound (11) 0 .493 g was obtained (yield 71.
8%). 1 H-NMR (TMS / CDC of the obtained compound
l 3 ) The results (ppm) of the analysis are shown below. 8.61 (s, 2H) 2.63 (t, 2H) 8.48 (d, 2H) 2.54 (m, 1H) 8.15 (d, 2H) 1.87-1.20 (m, 36
H) 7.32 (d, 2H) 1.16 (d, 6H) 6.98 (d, 2H) 0.88 (t, 3H) 4.05 (m, 4H) In addition, the compound ( The phase transition behavior (temperature lowering process) of 11) is as follows. Iso → N → S C → S 1 → Cryst. 115 ° C 99 ° C 38 ° C 32 ° C $ Example 19 Synthesis of Compound (12) Compound (12) was synthesized according to the synthetic route shown below.

【化22】 $ (19−1)化合物(31)の合成 安息香酸誘導体(30)1.32g、ヒドロキシフェニ
ルピリミジン誘導体(15)1.25g、DCC1.4
0g、DMAP0.156gのトルエン40ml溶液を
室温で12時間攪拌した。その後、ジクロロメタン20
0mlを加えて反応溶液を希釈した。瀘過を行い、瀘液
から減圧で溶媒を留去することで残渣6.76gを得
た。これをカラムクロマトグラフィー(中性アルミナ充
填プレカラム、シリカゲル充填メインカラム、10%酢
酸エチル/30%ジクロロメタン/n−ヘキサン展開)
により精製することで、目的とする化合物(31)1.
75gを得た(収率64.5%)。得られた化合物の1
H−NMR(TMS/CDCl3)分析の結果(ppm)を
下記に示す。 8.62(s,2H) 4.00(t,2H) 8.48(d,2H) 3.37(t,2H) 8.15(d,2H) 2.62(t,2H) 7.33(d,2H) 1.86−0.88(m,31
H) 6.97(d,2H) $ (19−2)化合物(12)の合成 (±)−2−メチルバレリックアシッドの代りにイソバ
レリックアシッドを、化合物(16)の代りに化合物
(31)を用い、実施例15と同様な操作を行うことに
より、化合物(31)0.680gから、目的とする化
合物(12)0.502gを得た(収率71.4%)。
得られた化合物の1H−NMR(TMS/CDCl3)分析の
結果(ppm)を下記に示す。 8.62(s,2H) 2.64(t,2H) 8.48(d,2H) 2.19(d,2H) 8.15(d,2H) 2.10(m,1H) 7.33(d,2H) 1.89−1.20(m,28
H) 6.98(d,2H) 0.96(d,6H) 4.06(m,4H) 0.88(t,3H) また、偏光顕微鏡観察による化合物(12)の相転移挙
動(降温過程)は以下の下の通りであった。 Iso → N → SC → Cryst. 116℃ 93℃ 51℃ $ 実施例20 化合物(13)の合成 以下に示す合成経路に従って化合物(13)を合成し
た。
[Chemical formula 22] $ (19-1) Synthesis of compound (31) 1.32 g of benzoic acid derivative (30), 1.25 g of hydroxyphenylpyrimidine derivative (15), DCC1.4
A solution of 0 g and 0.156 g of DMAP in 40 ml of toluene was stirred at room temperature for 12 hours. Then dichloromethane 20
The reaction solution was diluted by adding 0 ml. Filtration was performed, and the solvent was distilled off from the filtrate under reduced pressure to obtain 6.76 g of a residue. This is subjected to column chromatography (pre-column packed with neutral alumina, main column packed with silica gel, 10% ethyl acetate / 30% dichloromethane / n-hexane development).
The target compound (31) 1.
75 g was obtained (yield 64.5%). 1 of the resulting compound
The result (ppm) of 1 H-NMR (TMS / CDCl 3 ) analysis is shown below. 8.62 (s, 2H) 4.00 (t, 2H) 8.48 (d, 2H) 3.37 (t, 2H) 8.15 (d, 2H) 2.62 (t, 2H) 7. 33 (d, 2H) 1.86-0.88 (m, 31
H) 6.97 (d, 2H) $ (19-2) Synthesis of compound (12) Isovaleric acid instead of (±) -2-methylvaleric acid, compound (31) instead of compound (16) Was performed in the same manner as in Example 15 to obtain 0.502 g of the desired compound (12) from 0.680 g of the compound (31) (yield 71.4%).
The results (ppm) of 1 H-NMR (TMS / CDCl 3 ) analysis of the obtained compound are shown below. 8.62 (s, 2H) 2.64 (t, 2H) 8.48 (d, 2H) 2.19 (d, 2H) 8.15 (d, 2H) 2.10 (m, 1H) 7. 33 (d, 2H) 1.89-1.20 (m, 28
H) 6.98 (d, 2H) 0.96 (d, 6H) 4.06 (m, 4H) 0.88 (t, 3H) Also, the phase transition behavior of the compound (12) by polarization microscope observation (temperature decrease). The process) was as follows. Iso → N → S C → Cryst. 116 ° C. 93 ° C. 51 ° C. $ Example 20 Synthesis of compound (13) Compound (13) was synthesized according to the synthetic route shown below.

【化23】 $ (±)−2−メチルバレリックアシッドの代りにイソブ
チリックアシッドを、化合物(16)の代りに化合物
(31)を用い、実施例15と同様の操作を行うことに
より、化合物(31)0.680gから、目的とする化
合物(13)0.496gを得た(収率72.1%)。
得られた化合物の1H−NMR(TMS/CDCl3)分析の
結果(ppm)を下記に示す。 8.62(s,2H) 2.63(t,2H) 8.49(d,2H) 2.55(m,1H) 8.16(d,2H) 1.87−1.20(m,28
H) 7.33(d,2H) 1.17(d,6H) 6.97(d,2H) 0.88(t,3H) 4.06(m,4H) また、偏光顕微鏡観察による化合物(13)の相転移挙
動(降温過程)は以下の下の通りであった。 Iso → N → SC → glass 119℃ 88℃ 39℃ $ 実施例21、22、23、24、25及び26 強誘電性高分子液晶化合物(28)に、本発明の化合物
(8)、(9)、(10)、(11)、(12)及び
(13)を30重量%添加した液晶組成物を調製した。
液晶組成物の調製は、組成物の構成成分全てをその重量
の1.5倍の重量のジクロロメタンに溶解して均一溶液
とした後、溶媒を留去することによって行った。更に、
2枚のITO電極付ガラス基板間に、これらの組成物を
挟み、シアリング法によりセル厚約3μmの配向セルを
作製し、±15MV/mの電界を印加しながらチルト角
(2θ)を測定した。結果を表2に示す。また、得られ
たこれらの配向セルを2℃で放置し、結晶析出の様子を
顕微鏡で観察した。結果を表3に示す。
[Chemical formula 23] Compound (31) was obtained by the same procedure as in Example 15 using isobutyric acid instead of $ (±) -2-methylvaleric acid and compound (31) instead of compound (16). 0.496 g of the target compound (13) was obtained from 0.680 g (yield 72.1%).
The results (ppm) of 1 H-NMR (TMS / CDCl 3 ) analysis of the obtained compound are shown below. 8.62 (s, 2H) 2.63 (t, 2H) 8.49 (d, 2H) 2.55 (m, 1H) 8.16 (d, 2H) 1.87-1.20 (m, 28
H) 7.33 (d, 2H) 1.17 (d, 6H) 6.97 (d, 2H) 0.88 (t, 3H) 4.06 (m, 4H) In addition, the compound ( The phase transition behavior (temperature lowering process) of 13) is as follows. Iso → N → S C → glass 119 ℃ 88 ℃ 39 ℃ $ Examples 21-25 and 26 Ferroelectric liquid crystal polymer compound (28), the compounds of the present invention (8), (9 ), (10), (11), (12) and (13) were added at 30% by weight to prepare a liquid crystal composition.
The liquid crystal composition was prepared by dissolving all the constituent components of the composition in 1.5 times the weight of dichloromethane to form a uniform solution, and then distilling off the solvent. Furthermore,
These compositions were sandwiched between two glass substrates with ITO electrodes, an alignment cell having a cell thickness of about 3 μm was prepared by a shearing method, and a tilt angle (2θ) was measured while applying an electric field of ± 15 MV / m. . The results are shown in Table 2. Further, the obtained oriented cells were allowed to stand at 2 ° C. and the state of crystal precipitation was observed with a microscope. The results are shown in Table 3.

【表2】 表1及び表2より、本発明の化合物が大きなチルト角を
有する液晶組成物を調製できることがわかる。 比較例2〜34 前述の独国特許出願公開第4003012号明細書及び
欧州特許出願公開第0477901号明細書に記載の公
知の化合物[1]〜[33]30重量%と強誘電性高分
子液晶化合物(28)70重量%からなる液晶組成物を
実施例21〜26と同様にして調製し、同様に配向セル
を作製した。得られた配向セルを2℃で放置し、結晶析
出の様子を顕微鏡で観察した。結果を表3に示す。
[Table 2] From Table 1 and Table 2, it can be seen that the compound of the present invention can prepare a liquid crystal composition having a large tilt angle. Comparative Examples 2 to 34 Known compounds [1] to [33] 30% by weight described in German Patent Application Publication No. 4003012 and European Patent Application Publication No. 0477901 and ferroelectric polymer liquid crystals. A liquid crystal composition containing 70% by weight of the compound (28) was prepared in the same manner as in Examples 21 to 26, and an alignment cell was prepared in the same manner. The orientation cell obtained was left at 2 ° C., and the state of crystal precipitation was observed with a microscope. The results are shown in Table 3.

【表3】 $ 分岐中心炭素と骨格部との間のアルキレン基にヘテロ原
子からなる官能基を多くても1種しか持たない上記公知
の非光学活性な化合物を高分子液晶化合物と混合して液
晶組成物とした場合、短時間で結晶化による相分離を起
こすのに比較して、同アルキレン基に−COO−及び−
O−の2つの官能基を有する本発明の非光学活性低分子
化合物を配合した液晶組成物では結晶化が起こりにく
く、結晶化による相分離が抑制された長期的安定性に優
れる液晶組成物が得られることがわかる。
[Table 3] $ A liquid crystal composition is prepared by mixing the above-mentioned known non-optically active compound having at most one kind of functional group consisting of a hetero atom in the alkylene group between the branched central carbon and the skeleton with a polymer liquid crystal compound. In the case of causing the phase separation due to crystallization in a short time, the alkylene group has -COO- and-.
A liquid crystal composition containing a non-optically active low molecular weight compound of the present invention having two O-functional groups is less likely to crystallize, and a liquid crystal composition excellent in long-term stability in which phase separation due to crystallization is suppressed is provided. You can see that you can get it.

【発明の効果】本発明により、強誘電性高分子液晶と配
合することによって、チルト角の大きさが大きく、長期
にわたって相分離を起こさない安定した液晶組成物を得
ることができるという特異な性質を有する新規化合物が
得られた。
INDUSTRIAL APPLICABILITY According to the present invention, by blending with a ferroelectric polymer liquid crystal, it is possible to obtain a stable liquid crystal composition having a large tilt angle and causing no phase separation for a long period of time. A new compound having

【図面の簡単な説明】[Brief description of drawings]

【図1】実施例7で得られた本発明の非光学活性化合物
のNMRチャートである。
1 is an NMR chart of the non-optically active compound of the present invention obtained in Example 7. FIG.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C09K 19/20 Z 7457−4H 19/34 7457−4H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location C09K 19/20 Z 7457-4H 19/34 7457-4H

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式で表わされる非光学活性低分
子化合物。 【化1】 (式中、R1は 【化2】 を表わし、R2は炭素数4〜20の非光学活性なアルキル
基、lは0〜10の整数、mは0〜10の整数、nは1
〜10の整数、kは1〜20の整数、Yは単結合、O、CO
O又はOCOを表わす。)
1. A non-optically active low-molecular compound represented by the following general formula. [Chemical 1] (In the formula, R 1 is R 2 is a non-optically active alkyl group having 4 to 20 carbon atoms, l is an integer of 0 to 10, m is an integer of 0 to 10, and n is 1
-10 integer, k 1-20 integer, Y single bond, O, CO
Represents O or OCO. )
JP11525593A 1992-04-22 1993-04-20 Optically inactive low-molecular compound Pending JPH069503A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11525593A JPH069503A (en) 1992-04-22 1993-04-20 Optically inactive low-molecular compound

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12797892 1992-04-22
JP4-127978 1992-04-22
JP11525593A JPH069503A (en) 1992-04-22 1993-04-20 Optically inactive low-molecular compound

Publications (1)

Publication Number Publication Date
JPH069503A true JPH069503A (en) 1994-01-18

Family

ID=26453798

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11525593A Pending JPH069503A (en) 1992-04-22 1993-04-20 Optically inactive low-molecular compound

Country Status (1)

Country Link
JP (1) JPH069503A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020157719A (en) * 2019-03-28 2020-10-01 大日本印刷株式会社 Laminate, packaging material, packaging bag and stand pouch

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020157719A (en) * 2019-03-28 2020-10-01 大日本印刷株式会社 Laminate, packaging material, packaging bag and stand pouch

Similar Documents

Publication Publication Date Title
US4886623A (en) Ferroelectric smectic liquid crystal compound and composition containing the same
JPH069503A (en) Optically inactive low-molecular compound
JPH0764829B2 (en) Liquid crystal compound
JPH0680612A (en) Optically inactive liquid crystal compound
US4970023A (en) Biphenyl compounds, method of producing the same as well as liquid crystal compositions and light switch elements each containing the same
JP2830361B2 (en) Optically active compound and ferroelectric liquid crystal composition using the same
JPH07165672A (en) Optically inactive low-molecular compound
US5166391A (en) Optically-active aliphatic α-halogen substituted carboxylic acid 4&#39;-(alkoxybenzyloxy)biphenyl thioester compounds
US5210267A (en) Optically-active aliphatic β-halogen substituted carboxylic acid 4&#39;-(4-alkoxybenzyloxy)biphenyl thioester compounds and process for the preparation thereof
JP2786513B2 (en) Ester compound and liquid crystal composition containing the same
JPH0655694B2 (en) Liquid crystalline substance, method for producing the same and liquid crystal composition containing the same
JPH0625059A (en) Liquid crystal compound and composition
JP2796722B2 (en) Liquid crystal for optical elements
US5360575A (en) Lactic acid derivatives having two asymmetric carbon atoms, liquid crystal composition containing same and liquid crystal device
JPS61189263A (en) Liquid crystal compound, production thereof, and liquid crystal composition
JPH01311051A (en) Novel lactic acid derivative, liquid crystal composition containing said derivative and optical switching element
JP2561128B2 (en) Optically active compound and its use
JP2561054B2 (en) Optically active liquid crystal compound, additive for ferroelectric liquid crystal composition, and ferroelectric liquid crystal composition
JP2534547B2 (en) Liquid crystal compound and liquid crystal composition containing the same
JPH0733355B2 (en) Biphenylcarboxylic acid ester derivative and liquid crystal composition
JPH0517405A (en) Optically active compound and chiral smectic liquid crystalline composition using the same compound
JPH0517406A (en) Fluorine-containing compound and chiral smectic liquid crystalline composition using the same compound
EP0430205A2 (en) Liquid cristal display device
JP2002308860A (en) Thiadiazole-ring-containing compound, liquid crystal composition containing the same, and liquid crystal display element using the composition
JPH0710847A (en) New ester compound, mixed liquid crystal containing the same and light switching element

Legal Events

Date Code Title Description
A02 Decision of refusal

Effective date: 20040316

Free format text: JAPANESE INTERMEDIATE CODE: A02